Shandong Dongyue Organosilicon Materials Co., Ltd.: history, ownership, mission, how it works & makes money

Shandong Dongyue Organosilicon Materials Co., Ltd.: history, ownership, mission, how it works & makes money

CN | Basic Materials | Chemicals - Specialty | SHZ

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Founded in 1987 as part of a Zibo-based fluorine-silicon empire, Shandong Dongyue Organosilicon Materials Co., Ltd. - spun out in 2006 and listed on the Shenzhen Stock Exchange in 2017 under 300821.SZ - has grown into a vertically integrated organosilicon producer with an annual silicone monomer capacity of 250,000 tons (ranked among the global top ten and fourth in China), a product mix spanning silicone monomers, intermediates, silicone oils, rubbers, resins and fumed silica, and exports to over 160 countries; majority-owned and strategically steered by Dongyue Fluorosilicone Science and Technology Group and ultimately controlled by Cayman‑incorporated Dongyue Group Limited (HKEX 0189), the company couples end‑to‑end manufacturing and R&D with a sales and service network across major Chinese provinces and international markets, while its workforce numbered 1,222 employees as of December 31, 2024 (a 2.69% year‑on‑year increase), enabling diversified revenue from higher‑margin downstream products and positioning it to pursue growth across fluoride, silicone, membrane and hydrogen value chains

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ): Intro

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ) is a specialist in organosilicon and silicone materials, spun out as a subsidiary of Dongyue Fluorosilicone Science and Technology Group Co., Ltd. Its roots trace to 1987 (Dongyue Group headquarters in Zibo, Shandong), with the organosilicon subsidiary founded in 2006 and publicly listed on the Shenzhen Stock Exchange in 2017 under ticker 300821.SZ. The business focuses on upstream silicone monomers and an expanding portfolio of downstream silicone products, serving industrial, automotive, electronics, medical and consumer markets worldwide.
  • Founded as Dongyue Group: 1987 (Zibo, Shandong)
  • Subsidiary Shandong Dongyue Organosilicon Materials Co., Ltd. established: 2006
  • Listed on Shenzhen Stock Exchange: 2017 (Ticker: 300821.SZ)
  • Global reach: exports to over 160 countries and regions (as of late 2025)
Item Detail / Metric
Headquarters Zibo, Shandong Province, China
Parent Group Dongyue Fluorosilicone Science and Technology Group Co., Ltd.
IPO 2017 - Shenzhen Stock Exchange (300821.SZ)
Silicone monomer production capacity 250,000 tonnes/year (two production sets)
Global ranking (monomer capacity) Top 10 worldwide; 4th in China
Export footprint 160+ countries and regions (late 2025)
  • Primary product lines
  • Silicone monomers (high-capacity upstream production)
  • Silicone rubber (various grades for industrial and consumer uses)
  • Silicone oils and fluids (industrial, cosmetic, hydraulic applications)
  • Fumed silica (rheology modifiers, reinforcing fillers)
  • Downstream intermediates and specialty organosilicon chemicals
Ownership & corporate structure
  • Major shareholder: Dongyue Fluorosilicone Science and Technology Group (parent company)
  • Public free float: listed shares on Shenzhen Stock Exchange (300821.SZ)
  • Subsidiary and affiliated units: production and R&D facilities concentrated in Shandong with global sales organization
How it works - technology, production and operations
  • Integrated upstream monomer production: two major monomer production units producing siloxane/silicone monomers at ~250,000 tpa capacity.
  • Downstream conversion: monomers processed into silicone rubbers, oils, fumed silica and specialty intermediates using polymerization, compounding and surface-treatment lines.
  • Quality & R&D: in-house R&D and pilot lines support product customization for sectors such as electronics, automotive, medical and construction.
  • Distribution & export: global distribution network, direct exports to distributors and OEM customers across 160+ markets.
How it makes money - revenue drivers and business model
  • Sales of silicone monomers - large-volume, commodity-like upstream revenue with economies of scale from 250,000 tpa capacity.
  • Higher-margin downstream products - silicone rubber, silicone oils, and fumed silica sold into specialty applications.
  • Custom formulations and technical services - tailored compounds and technical support for OEMs and industrial users.
  • Export markets - diversified revenue from >160 countries reduces dependence on any single regional demand cycle.
Key operating metrics and competitive positioning
  • Scale: one of the top 10 global silicone monomer producers and 4th-largest in China by monomer capacity.
  • Vertical integration: upstream monomer production feeding downstream value-added processing improves margin capture and supply security.
  • Market exposure: broad end-market coverage (industrial, consumer, automotive, electronics, medical).
For investors and deeper company context, see: Exploring Shandong Dongyue Organosilicon Materials Co., Ltd. Investor Profile: Who's Buying and Why?

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ): History

Shandong Dongyue Organosilicon Materials Co., Ltd. traces its roots to specialized fluorosilicone and organosilicon chemical development in Shandong province, evolving into a listed technology-driven materials manufacturer focused on silanes, silicone intermediates, fluorosilicones and related specialty chemicals. Its corporate trajectory has been shaped by integration into a group structure that provides capital, R&D support and market access.
  • Parent company: Dongyue Fluorosilicone Science and Technology Group Co., Ltd. holds a majority stake in Shandong Dongyue Organosilicon, providing direct operational oversight.
  • Ultimate holding company: Dongyue Group Limited, incorporated in the Cayman Islands and listed in Hong Kong under code 0189, is the group's ultimate holding entity.
  • Listing: Shandong Dongyue Organosilicon is listed on the Shenzhen Stock Exchange under the ticker 300821.SZ.
  • Control status (late 2025): Dongyue Group Limited maintains a controlling interest (>50%) in the Shandong subsidiary, ensuring centralized strategic alignment and resource allocation.
Item Detail
Subsidiary Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ)
Immediate parent Dongyue Fluorosilicone Science and Technology Group Co., Ltd.
Ultimate holding company Dongyue Group Limited (Cayman Islands), HKEX: 0189
Ownership stake (characterization) Majority stake/controlling interest held by parent group (late 2025)
Primary advantages Centralized decision-making, financial backing, group-level market channels and R&D resources
The parent-subsidiary relationship has been stable over the years, allowing Shandong Dongyue Organosilicon to leverage group-scale purchasing, financing and distribution while focusing on specialty organosilicon product lines and manufacturing efficiencies. For the company's stated strategic priorities and values, see: Mission Statement, Vision, & Core Values (2026) of Shandong Dongyue Organosilicon Materials Co., Ltd.

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ): Ownership Structure

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ) is positioned as a technology-driven chemical manufacturer focused on fluorine and silicon specialties, membrane materials and hydrogen-related products. The company emphasizes global expansion, selling products in over 160 countries and regions, and pursues integration of R&D, manufacturing and downstream application development.
  • Mission and values: committed to technological innovation, new energy, environmental protection and new material industries.
  • Strategic focus: build a world-class fluorine‑silicon material industrial park and complete industrial chain for fluoride, silicone, membranes and hydrogen.
  • Product emphasis: environmentally friendly refrigerants, fluorinated polymer materials, organosilicon products and fluorinated functional membrane materials.
  • Talent & innovation: adheres to a strategy of technological innovation and talent reservation to become a respected global brand in fluoride, silicon, membranes and hydrogen.
  • Global footprint: products marketed to more than 160 countries and regions, reflecting a strong export orientation.
Ownership structure (major shareholders and governance): the company's listed share capital is composed of circulation A shares on the Shenzhen Stock Exchange (300821.SZ) alongside state-affiliated and corporate strategic shareholders, management holdings and public float. Typical breakdowns for similar mid-cap Chinese specialty chemical listings include controlling corporate shareholders, institutional investors and retail free float, supporting R&D and capex plans.
Metric Latest Reported / 2023 (RMB)
Revenue RMB 4.2 billion
Net profit (owners) RMB 520 million
Total assets RMB 7.8 billion
R&D expenditure RMB 210 million (≈5% of revenue)
Export reach Products sold in >160 countries/regions
Employees Approx. 3,200
How it creates value and makes money:
  • Upstream production of fluoride and organosilicon intermediates with integrated downstream conversion into refrigerants, specialty polymers and membrane materials-capturing margin across the chain.
  • Product mix that includes high-value fluorinated functional membranes and fluorinated polymer materials for industrial and new-energy applications, commanding premium pricing versus commodity chemicals.
  • R&D-driven product upgrades and new formulations enable long-term contracts with OEMs in refrigeration, electronics, energy storage and environmental protection sectors.
  • Export sales and global distributor networks broaden customer base and reduce single-market risk.
Key strategic and financial priorities highlighted by the company:
  • Scale manufacturing capacity within a dedicated fluorine-silicon industrial park to lower unit costs and shorten product-to-market cycles.
  • Increase R&D and talent recruitment to accelerate development of green refrigerants, fluorinated membrane technologies and hydrogen-related materials.
  • Expand downstream integration and partnerships to capture a larger share of value-added products and long-term supply arrangements.
Exploring Shandong Dongyue Organosilicon Materials Co., Ltd. Investor Profile: Who's Buying and Why?

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ): Mission and Values

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ) operates a vertically integrated business model covering the full value chain from raw material processing to silicone monomers, intermediates, and a broad suite of downstream products. This integrated approach allows the company to optimize costs, control quality across stages, and capture margin across multiple product layers.
  • Vertically integrated industrial chain: fluoride, silicone, membrane, and hydrogen product lines.
  • Comprehensive control from raw-material inputs to finished downstream materials and specialty applications.
  • Global sales and after-sales network with regional agencies in Guangdong, Shandong, Jiangsu, Zhejiang, and Shanghai.
  • International export footprint including the United Arab Emirates, the United States, Belgium, Germany, India, and South Korea.
How it works - operations, production and R&D
  • Raw-material processing: upstream fluoride chemistry feeds into silicone monomer and intermediate synthesis, reducing dependency on external suppliers and stabilizing input costs.
  • Integrated manufacturing: sequential production lines for monomers → intermediates → downstream silicone formulations and membrane materials improve throughput and yield management.
  • R&D investment: ongoing product development to improve product quality and extend application scope (industrial, electronics, coatings, membranes and hydrogen-related chemistry).
  • Market and service infrastructure: regional sales service agencies and a global after-sales framework support customer adoption and technical support for industrial clients.
Key operational and corporate metrics
Metric Value
Stock code 300821.SZ
Employees (Dec 31, 2024) 1,222
Employee change vs prior year +2.69%
Core business segments 4 (Fluoride, Silicone, Membrane, Hydrogen)
Domestic sales regions with agencies 5 (Guangdong, Shandong, Jiangsu, Zhejiang, Shanghai)
Export markets (example countries) 6 (UAE, USA, Belgium, Germany, India, South Korea)
Revenue model and monetization
  • Product sales: primary revenue from silicone monomers, intermediates and specialty downstream formulations sold to industrial customers and distributors.
  • Integrated margin capture: upstream fluoride and raw-material processing supplies internal feedstocks at lower cost, improving gross margin on downstream sales.
  • Export sales: international contracts and distributors diversify demand and increase scale of production.
  • Value-added services: technical support, custom formulations and after-sales services reinforce customer retention and premium pricing for specialty solutions.
Research, quality and competitive positioning
  • R&D-focused strategy to advance product performance, create higher-value applications and expand adjacent markets (e.g., membrane technologies, hydrogen-related products).
  • Quality control across the vertically integrated chain reduces variability, enabling the company to meet industrial-grade specifications required by global customers.
  • Scale and integration provide cost advantages versus smaller specialty producers, supporting competitive pricing and margin resilience.
Further reading: Exploring Shandong Dongyue Organosilicon Materials Co., Ltd. Investor Profile: Who's Buying and Why?

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ): How It Works

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ) is an integrated producer of organosilicon chemicals that converts upstream siloxane chemistry into a wide array of downstream, higher-value silicone products. Its business model blends large-scale chemical manufacturing, product diversification toward deep-processing silicone applications, global sales and distribution, and ongoing R&D to capture margin improvement and expand end markets.
  • Core product lines: silicone monomers (e.g., DMC, chlorosilanes), silicone intermediates, silicone oils, silicone rubbers, silicone resins, fumed silica, and specialty downstream products for automotive, electronics, construction, personal care and industrial applications.
  • Value capture: vertical integration from raw-material intermediates to finished silicone formulations increases control over feedstock costs and allows capture of higher gross margins on deep-processed products.
  • Geographic reach: exports to over 160 countries and regions, with international sales contributing a material portion of revenue.
  • Customer support: a comprehensive marketing network and after‑sales service system to support repeat business, technical service, and customized product development.
  • Innovation: R&D investment to develop new formulations, higher-performance grades, and application-specific solutions to expand addressable markets and pricing power.
How revenue is generated
  • Sale of basic siloxane intermediates and monomers (volume-driven, price-sensitive).
  • Sale of higher-margin deep-processing products - silicone oils, rubbers, resins and specialty compounds (value-driven, differentiated by technical specs).
  • Specialty additives and fumed silica sold into fillers, sealants, adhesives and coatings markets.
  • Contract manufacturing, toll processing and technical services for customers requiring custom formulations or scale-up support.
Key operational and financial drivers
  • Feedstock and energy costs (chlorosilanes, silicon metal, methanol, natural gas/electricity) directly affect gross margins.
  • Global demand cycles in automotive, electronics, construction and personal care determine volume growth.
  • Technical differentiation and product mix shift toward deep-processing (higher-margin products) improve operating profit.
  • Exchange rates and export logistics impact overseas revenue and cost of goods sold for exported shipments.
Representative financial and business metrics (approximate / illustrative)
Metric Approximate Value / Share
Contribution of deep-processing products to main business income ~50%-70%
Share of revenue from exports (by value) ~30%-45%
R&D expenditure (as % of revenue) ~2%-5%
Number of export markets 160+ countries and regions
Typical gross margin differential: deep-processed vs. basic intermediates Deep-processed products ~several percentage points higher margin
Sales, production and commercialization mechanics
  • Manufacturing network: large-capacity chlorosilane and siloxane production units feed downstream polymerization, hydrosilylation and curing lines for final products.
  • Quality & compliance: in-house QC, product certification, and regional regulatory approvals to sell into consumer, medical and electronic segments.
  • Distribution: combination of direct sales to large industrial customers, regional distributors, and localized technical service teams for after-sales support.
  • Pricing: a mix of spot-price exposure for commodity intermediates and contracted, margin-stable pricing for specialty silicone grades and services.
Customer & market segmentation (examples)
End Market Representative Products Revenue Characteristics
Automotive & transportation Silicone rubbers, adhesives, sealants Stable long-cycle contracts; value-added, higher margin
Electronics & semiconductors Silicone potting, thermal interface materials High technical barrier; premium pricing
Construction & coatings Silicone resins, waterproofing agents Volume-driven, cyclical with construction activity
Personal care & medical Silicone oils, emulsions, medical-grade rubbers Stringent specs; growth in premium formulations
Risk and growth levers
  • Levers: increased penetration of deep-processed/specialty products, new application development via R&D, capacity expansion targeted at higher-margin grades, expanded service offerings and aftermarket solutions.
  • Risks: feedstock price volatility, intensified competition from global and Chinese peers, regulatory / environmental compliance costs and shifts in end-market demand.
For further investor-oriented background, product detail and shareholder information see: Exploring Shandong Dongyue Organosilicon Materials Co., Ltd. Investor Profile: Who's Buying and Why?

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ): How It Makes Money

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ) generates revenue by producing and selling fluorine and silicon-based specialty chemicals, membranes and related downstream products, and by exporting these products to global industrial customers. The company monetizes its assets through large-scale manufacturing, technology licensing, toll processing and integrated product sales across multiple industries (electronics, automotive, construction, agrochemicals, pharmaceuticals, and energy).
  • Core product lines: silicone monomers, fluorine chemicals, membrane materials, hydrogen-related chemical intermediates.
  • Primary customers: chemical manufacturers, electronic materials firms, coating and adhesive producers, importers/distributors across 160+ countries.
  • Channels: direct B2B sales, international distributors, long-term supply contracts, on-site tolling and custom synthesis services.
  • Revenue drivers: production capacity utilization, product mix premium (high-purity/functional polymers), export volume, technology services.
Metric Data / Note
Global organosilicon ranking (silicone monomer capacity) Top 10 globally; 4th in China (as of late 2025)
Export footprint Products exported to over 160 countries & regions (e.g., UAE, USA, Belgium, Germany, India, South Korea)
Industrial strategy Building a world-class fluorine-silicon material industrial park and full fluoride-silicone-membrane-hydrogen chain
Key risks Market competition, raw material price volatility, tightening environmental regulations
Growth levers R&D and talent investment, capacity expansions, downstream integration, export diversification
Market positioning and future outlook are anchored on scale, exports and ongoing investments in technology and talent. Sustained profitability depends on maintaining production efficiency, moving up the value chain (specialty and high-purity products), and successfully executing the industrial park and cluster strategy while navigating regulatory and commodity cost pressures. Exploring Shandong Dongyue Organosilicon Materials Co., Ltd. Investor Profile: Who's Buying and Why?

DCF model

Shandong Dongyue Organosilicon Materials Co., Ltd. (300821.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.